Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
the A.I. Virtanen Institute for Molecular Sciences at the University of Eastern Finland (Kuopio campus) for a Research Council of Finland–funded project developing a novel MRI method for measuring brain
-
, funded by the Research Council of Finland, synergizes modern computational methods for analyzing large histological image volumes, new magnetic resonance imaging techniques, and statistical physics
-
), including the brain and spinal cord, using advanced imaging methods. By developing a novel functional magnetic resonance imaging (fMRI) technique, this project aims to simultaneously capture activity in
-
the introduction of various solvents, environmentally friendly materials, solid electrolytes, and printing methods. Who are you In order to succeed and enjoy the position, we expect from you: You hold a Master’s
-
drug design” is led by Docent Juri Timonen, at the Division of Pharmaceutical Chemistry and Technology. Our aim is to create new machine learning and artificial intelligence methods to accelerate drug
-
engineering, including the current and emerging needs of the software industry 2) Expertise in sustainable software engineering practices, tools, and methods with a focus on integrating sustainability across
-
software engineering practices, tools, and methods with a focus on integrating sustainability across all phases of the software development lifecycle (agile software development, CI/CD) Ability to assess and
-
LIBERAL ARTS AND SCIENCES / DIGITAL HUMANITIES for a fixed-term appointment 1.1.2026-30.11.2027. The position relates to the application of computational and/or statistical methods in the humanities
-
theoretical background and a degree in cell and molecular biology (or similar field) and preferably some practical experience in cell culture and/or functional genomics methods. For the Doctoral Researcher
-
. We develop machine learning methods tailored for high-dimensional, multimodal biological data, with applications ranging from single-cell genomics to real-world clinical datasets. We are active